Laidlaw analyst Yale Jen reiterated a Buy rating and $79.00 price target on Arcturus Therapeutics (NASDAQ: ARCT).The analyst commented, "Yesterday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE